R & D team
HEC is a high-tech large-scale joint-stock enterprise full of hope, focusing on industry and building a century-old foundation.
HEC is a high-tech large-scale joint-stock enterprise full of hope, focusing on industry and building a century-old foundation. It has more than 20,000 employees; it is mainly engaged in three major industries: "electronic new materials", "biomedicine" and "health and wellness". Now there are seven bases, located in Dongguan in Guangdong, Shaoguan in Guangdong, Yichang in Hubei, Dongyang in Zhejiang, Ulanchap in Inner Mongolia, Zunyi in Guizhou, and Nyingchi in Tibet. It has two listed companies: HEC (600676.SH) and HEC Pharmaceutical (01558.HK).
New Electronic Materials
Health And Wellness
New Electronic Materials
New electronic materials - The new electronic material industry already owns an A-share listed company HEC (600673.SH); it develops core industries around the capacitor industry chain and battery material industry clusters, and has created four major industry clusters: electronic component, high-end aluminum foil, new chemical material, and new energy material. Relying on the complete industry chain and technological innovation advantages, it actively responds to the national "double carbon" policy, closely focuses on market demand, continuously improves the industrial layout, and strives to build an internationally advanced new energy material platform company within 5-8 years!Learn mode →
Biomedicine industry- The biomedical industry mainly includes Sunshine Lake Pharma Co., Ltd. and HEC Pharm Co., Ltd. two business systems. Sunshine Lake Pharma Co., Ltd. includes HEC Pharmaceutical Research Institute, domestic preparation business ("HEC Changjiang Pharmaceutical", which has been listed in Hong Kong stock market) and pharmaceutical business for foreign markets; HEC Pharm Co., Ltd. is mainly engaged in bio-fermentation API.Learn mode →
Health And Wellness
Health and wellness - HEC Health has a research institute with more than 200 high-end R&D talents, and has built an industrialization base mainly in Yichang, Hubei, supplemented by Shaoguan, Guangdong and Nyingchi, Tibet. In the future, the research and development and production base of Cordyceps sinensis deep processing products will be built in Zhuhai Hengqin and Dongyang, Zhejiang. Adhering to the concepts of safety, health, ecology and high technology, HEC will build a large-scale health industry dominated by Cordyceps sinensis, and continue to develop and innovate ecologically bred Cordyceps sinensis and its deep-processed products, health food, health care products, cosmetics and other large-scale health products cluster.Learn mode →
R & D Center
In 2005, HEC established the General Research Institute, which consists of three branches: the Pharmaceutical Research Institute, the Great Health Research Institute and the New Energy Research Institute. Through 17 years of unremitting efforts, it has possessed continuous and systematic research and development capabilities. The research and development concept is occidentalized, the scientific research talents are globalized, and the research and development and testing equipment are first-class.
The institute has more than 20 foreign and returnee experts, more than 100 doctors, more than 1,000 masters, more than 1,700 R&D personnel, and has first-class medicinal chemistry capabilities, thus forming a unique R&D model of "domestic elite-led, returnee expert guidance, overseas consultant guidance”.
The institute has applied for more than 3,500 patents, and its foreign patents are more than 1,500; the total number of pharmaceutical patents, compound patents, compound PCT patents, patent application growth rate and patent quality applied by HEC drugs each year rank in the forefront of China.
Dongguan Base, Guangdong
Group headquarters, research institutes and pharmaceutical production sites (pharmaceutical research institutes are actively preparing for listing)
Shaoguan Base, Guangdong
Location of A-share HEC (600673. SH) listed company, focusing on new electronic materials, fluorochemicals and new energy industries
Hong Kong HEC (01558. HK) is the place where the listed company is located, focusing on medicine, cordyceps and other industries
Dongyang Base, Zhejiang
The third largest production base of HEC Group with capacitor as the core
Ulanchap Base, Inner Mongolia
Formed Foil Production Base
Zunyi Base, Guizhou
Energy reserve base
Cordyceps sinensis industry supporting base
Foreign markets account for nearly15%
Coordinated development of five platforms (HEC technology sales platform, HEC pharmaceutical sales platform, HEC health sales platform, API sales department, overseas sales department)
HEC Overseas Sales Department has established 15 overseas branches in Japan, the United States, Germany, Australia, the United Kingdom, South Korea, Indonesia, France, India and other developed countries.
More than 4,000 full-time sales staff